about
The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targetsTrans-arterial embolisation therapies for unresectable intrahepatic cholangiocarcinoma: a systematic reviewEndoscopic versus Percutaneous Biliary Drainage in Palliation of Advanced Malignant Hilar Obstruction: A Meta-Analysis and Systematic ReviewSurvival of surgery for recurrent biliary tract cancer: a single-center experience and systematic review of literature.Anticholangiocarcinoma activity and toxicity of the Kaempferia galanga Linn. Rhizome ethanolic extract.L1 Cell Adhesion Molecule Promotes Migration and Invasion via JNK Activation in Extrahepatic Cholangiocarcinoma Cells with Activating KRAS Mutation.Second-line systemic treatment for advanced cholangiocarcinomaKnockdown of anterior gradient 2 expression extenuates tumor-associated phenotypes of SNU-478 ampulla of Vater cancer cells.FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinomaTranscatheter arterial chemoembolization with gemcitabine and oxaliplatin for the treatment of advanced biliary tract cancer.Intramedullary spinal cord metastasis of cholangiocarcinoma: a case report.A case of metastatic renal cell carcinoma and bile duct carcinoma treated with a combination of sunitinib and gemcitabine.Endoscopic radiofrequency ablation may be preferable in the management of malignant biliary obstruction: A systematic review and meta-analysis.Combination of anti-L1 cell adhesion molecule antibody and gemcitabine or cisplatin improves the therapeutic response of intrahepatic cholangiocarcinomaRetinoid X receptor α enhances human cholangiocarcinoma growth through simultaneous activation of Wnt/β-catenin and nuclear factor-κB pathwaysApatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinoma.Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma.Classifying extrahepatic bile duct metachronous carcinoma by de novo neoplasia site.Synergistic antitumor activity of the combination of salubrinal and rapamycin against human cholangiocarcinoma cells.Endoscopic treatment options for cholangiocarcinomas.Palliation: Hilar cholangiocarcinoma.Advances in the surgical treatment of hilar cholangiocarcinoma.Prevalence of CTR1 and ERCC1 Polymorphisms and Response of Biliary Tract Cancer to Gemcitabine-Platinum ChemotherapyIn Vitro and In Vivo Inhibitory Effects of α-Mangostin on Cholangiocarcinoma Cells and AllograftsAdvanced biliary tract cancer: clinical outcomes with ABC-02 regimen and analysis of prognostic factors in a tertiary care center in the United States.Radiofrequency ablation for management of malignant biliary obstruction: a single-center experience and review of the literature.Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers.Regional thermochemotherapy versus hepatic arterial infusion chemotherapy for palliative treatment of advanced hilar cholangiocarcinoma: a retrospective controlled study.Impact of Radiofrequency Ablation on Malignant Biliary Strictures: Results of a Collaborative Registry.A case of advanced intrahepatic cholangiocarcinoma accidentally, but successfully, treated with capecitabine plus oxaliplatin (CAPOX) therapy combined with bevacizumab: a case reportExpression and prognostic value of glutamate dehydrogenase in extrahepatic cholangiocarcinoma patients.Synergistic Effect of Forbesione From Garcinia hanburyi in Combination with 5-Fluorouracil on CholangiocarcinomaDisruption of endocytic trafficking protein Rab7 impairs invasiveness of cholangiocarcinoma cells.Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study.Cholangiocarcinoma: molecular imaging-guided radiofrequency hyperthermia-enhanced intratumoral herpes simplex virus thymidine kinase gene therapy.Novel Potential Biomarkers for Infection and Associated CholangiocarcinomaPhase I study of adjuvant gemcitabine or S-1 in patients with biliary tract cancers undergoing major hepatectomy: KHBO1003 study
P2860
Q26751224-77A6A2A5-A570-4812-B13E-642C8927A712Q26781036-17D6A53A-7EF4-4883-9577-BC2901C57C33Q28075370-0BF4D7A9-BF12-4FD9-9CD3-273D1BD8A7E5Q30240120-1B8D9DFC-CAC2-49CB-B76D-2707061F2687Q33557221-6BC38F0F-81BB-4DBA-AC8C-2FF3A65AFA6CQ33775133-1C2150B0-C08E-45DA-A4E9-FD4D14EF096AQ34484299-93EA027F-B446-493B-8CEA-5E86E5059098Q34492618-0D827807-97DB-4C18-B3D8-C1555E706472Q35078039-E4416327-2BE6-4BC0-B073-C4CF349D62B6Q35179917-0FD5BD63-38D5-4BCC-BE2C-2173BC3DC5DAQ35608758-C615D4E7-50C3-4C45-90CF-FB23F0E380B5Q35639659-BA13C42A-A57B-4439-A02C-E4E787B056F6Q36171028-B11144AF-978E-4A60-A021-6C1471FB6EC9Q36271598-1E21788F-0A55-46B3-B64F-FA56B92B405AQ36467491-09F16958-D429-46DD-83B2-4A48711A8AEAQ37086246-9CE130B6-4E72-481D-BC43-FE02EAB022A8Q37392975-5C662EE5-0E69-4B17-8892-4A96FDDEAC2CQ37654454-9152E3E4-94BA-491A-A716-47AE94ED49ABQ37709171-C4283363-88F9-46E9-8AD8-9418C101B1C4Q38186132-9D058416-AE75-422F-B0E8-39C6CE52D80AQ38251703-EA238613-055F-40FF-B4B1-726157F89D83Q38254320-66A18217-07A7-46CB-AB7A-B18422B79836Q38690862-8933F413-131D-4D42-92B2-3B423FB87114Q38706139-DDAA1FD1-0205-4E2C-9A1D-518503F058F9Q39025911-91B1375C-C9C4-4801-91EC-AE8F2FABBD21Q39210789-D49C54A7-470C-471D-8FE3-91BF3F055D57Q39662945-FD4AD4E8-D90E-40B9-A325-17E41D8FFE22Q40046782-5B011E40-7787-4ABF-A355-18D1ABA644C0Q41379167-CC724CA3-4D31-4C4D-BF0A-6CC9D7DD854CQ42019361-E7A654A8-464E-4914-B9F4-B716B28D5A1AQ42242026-59F6EFA3-A8CC-417E-B4F5-D8E549C1E078Q47246118-A9610A6D-3623-4877-8470-9C56506841D4Q47746007-D5853679-0322-4951-9220-77950691B0A2Q49178298-6F9F30FB-AC10-41DF-B865-5527FB100424Q53831194-7816448D-1D0D-4875-BBDE-A561F1F27B4BQ57115768-47DBD05E-E954-49A1-9C66-4B3700D54EE9Q57149389-FA535A4B-1AA6-4F00-9860-E29375ACFE97
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chemotherapy for cholangiocarcinoma: An update.
@en
Chemotherapy for cholangiocarcinoma: An update.
@nl
type
label
Chemotherapy for cholangiocarcinoma: An update.
@en
Chemotherapy for cholangiocarcinoma: An update.
@nl
prefLabel
Chemotherapy for cholangiocarcinoma: An update.
@en
Chemotherapy for cholangiocarcinoma: An update.
@nl
P2093
P2860
P356
P1476
Chemotherapy for cholangiocarcinoma: An update.
@en
P2093
Hernán Cortés-Funes
Natalia Ramírez-Merino
Santiago Ponce Aix
P2860
P304
P356
10.4251/WJGO.V5.I7.171
P577
2013-07-01T00:00:00Z